Regional Review: Raleigh-Durham's Life Sciences Cluster Expands

By Eleana Teran

Raleigh-Durham is emerging as a national leader in biomanufacturing, driven by surging U.S. demand and global supply chain shifts. Anchored by Research Triangle Park and top-tier universities, the region attracted billions in new investments in 2025, including major projects from FUJIFILM, Biogen, and Novartis. These expansions underscore North Carolina’s competitive edge: cost efficiency, research depth, and a robust talent pipeline. Yet rapid growth brings challenges—tightening lab space, workforce development needs, and infrastructure pressures. State initiatives like Propel NC and expanded apprenticeships aim to sustain momentum and meet industry demands. Explore how these dynamics are reshaping the life sciences landscape and what they mean for future investment strategies.

Read the full article for insights into opportunities and constraints shaping this fast-growing market.